The Pathologist / Issues / 2026 / June / Beating Tissue Failure in Oncology
Histology Precision medicine Bioinformatics Digital and computational pathology Screening and monitoring Software and hardware Technology and innovation Digital Pathology

Beating Tissue Failure in Oncology

A patented AI platform trained on NYU Langone research is predicting cancer mutations from haematoxylin and eosin alone — closing the gap for the 25 percent of patients who never reach molecular testing

By Helen Bristow 06/04/2026 Interview 5 min read

Share

Top Institutions in Oncology

Ranking is based on citation frequency across our internal corpus of peer-reviewed articles.

  • #1

    NYU Langone Health

    New York, NY

    Strong presence in molecular pathology and oncology research.

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center

    New York, NY

    Notable for its focus on cancer survivor health care.

    Key Differentiators

    • Oncology

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Recommended

Related Content

A Helping Hand from AI in Prostate Cancer Diagnostics
Precision medicine
A Helping Hand from AI in Prostate Cancer Diagnostics

February 8, 2022

3 min read

Using AI to enhance personalized healthcare for patients with prostate cancer

The Ultimate Vision for Rare Disease
Precision medicine
The Ultimate Vision for Rare Disease

February 28, 2022

1 min read

Genomics and computational pathology can take rare disease diagnostics to the next level

A Light in the Darkness
Precision medicine
A Light in the Darkness

March 4, 2022

2 min read

Spectroscopic liquid biopsy testing – a new route to brain cancer diagnostics

In-House Matters
Precision medicine
In-House Matters

April 7, 2022

3 min read

Molecular pathology is complex – and the benefits of keeping it local are extensive